Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 807-272-7 | CAS number: 7182-21-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- The study was conducted between 07 October 2014 and 09 October 2014.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study is considered to be a reliability 1 as it has been conducted according to the Assessment of Ocular Irritation Potential using the SkinEthic Reconstructed Human Corneal Epithelial Model and in compliance with GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2014
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- This method was designed to be compatible with the following:
Prevalidation of a new in vitro reconstructed human cornea model to assess the eye irritating potential of chemicals (Van Goethem et al, 2006).
The SkinEthicTM HCE model, although not yet formally validated, has undergone successful pre-validation. The method followed forms part of a currently ongoing Colipa/ECVAM Eye Irritation Validation Study designed to offer a replacement to the in vivo rabbit eye test.
The experimental design of the study consists of a test for direct reduction of MTT (3 [4,5 dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) by the test item followed by the main test.
For the main test, triplicate SkinEthic tissues were treated with the test item for 10 minutes. At the end of the exposure period each SkinEthic tissue was rinsed. The rinsed tissues were taken for MTT-loading. After MTT-loading the tissues were removed and immersed in isopropanol for extraction of formazan crystals out of the MTT loaded tissues.
After extraction the absorbency of triplicate aliquots of the extracted MTT solution for each SkinEthic tissue was measured. The optical density was measured at 562 nm (OD562). Data are presented in the form of percentage viability (MTT conversion relative to negative controls). - GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- 3-methyl-1-benzofuran-5-ol
- EC Number:
- 807-272-7
- Cas Number:
- 7182-21-0
- Molecular formula:
- C9H8O2
- IUPAC Name:
- 3-methyl-1-benzofuran-5-ol
- Test material form:
- other: Solid
- Details on test material:
- Identification: IFF TM 11-0230
Physical state/Appearance: Beige solid
Storage Conditions: Room temperature in the dark
Constituent 1
Test animals / tissue source
- Species:
- other: SkinEthic Reconstructed Human Corneal Epithelial Model
- Strain:
- other: Not applicable
- Details on test animals or tissues and environmental conditions:
- Test System
Human Corneal Epithelium (HCE)
Supplier: SkinEthic Laboratories, Lyon, France
Date received: 07 October 2014
HCE Tissues (0.5cm2) batch number: 14-HCE-040
Maintenance Medium lot number: 14-MIMA-042
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- not required
- Amount / concentration applied:
- Triplicate tissues were treated with 30 mg of the test item
- Duration of treatment / exposure:
- 10 minutes
- Observation period (in vivo):
- 3 hours
- Number of animals or in vitro replicates:
- Not applicable
- Details on study design:
- Test System
Human Corneal Epithelium (HCE)
Supplier: SkinEthic Laboratories, Lyon, France
Date received: 07 October 2014
HCE Tissues (0.5cm2) batch number: 14-HCE-040
Maintenance Medium lot number: 14-MIMA-042
Test Item Formulation and Experimental Preparation
The test item was used as supplied.
Preparation of Negative and Positive Control Items
The negative control item, Solution A, was used as supplied. The positive control item, Sodium Dodecyl Sulphate 2% w/v, was prepared in sterile water.
Study Design
Pre-Test – Assessment of Direct Test Item reduction of MTT
The MTT assay, a colorimetric method of determining cell viability, is based on reduction of the yellow tetrazolium salt (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) to a blue formazan dye by mitochondrial succinate dehydrogenase in viable cells.
One limitation of the assay is possible interference of the test item with MTT. A test item may directly reduce MTT to formazan, thus mimicking dehydrogenase activity of the cellular mitochondria of viable cells. This property of the test item is only a problem, if at the time of the MTT test (after the chemical has been rinsed off) there are still sufficient amounts of the test item on or in the tissues. To identify this possible interference, the test item was checked for its ability to reduce MTT directly.
30 mg of test item was added to 1 mL of a 0.5 mg/mL MTT solution and incubated at 37 °C, 5% CO2 in air for 3 hours. Untreated MTT solution was used as a control. If the MTT solution turned blue, the test item was presumed to have reduced the MTT.
The test item was found to have the ability to directly reduce MTT and therefore the following procedure, employing freeze-killed tissues that possess no metabolic activity but absorb and bind the test item like viable tissues, was required.
In addition to the normal test procedure, the MTT reducing test item was applied to one freeze-killed tissue. One freeze-killed tissue remained untreated. The untreated freeze-killed tissue demonstrates a small amount of MTT reduction due to residual reducing enzymes. Freeze-killed tissues were prepared by placing untreated SkinEthic HCE tissues in a freezer (-14 to -30 ºC) overnight. Once killed, the tissues were stored in the freezer.
Receipt and Preparation of Tissues
On arrival, the SkinEthic HCE tissues (Day 6 cultures), were stored at room temperature prior to transferring into 24-well plates designated ‘arrival plates’ containing 300 μL of maintenance medium. It was important to ensure that there were no air bubbles present under the tissue inserts. The tissues were incubated overnight at 37 °C, 5% CO2 in air.
Main Test
Using sterile techniques, 1 mL of maintenance medium at room temperature, was dispensed into the appropriate number of wells of 6-well plates designated ‘treatment plates’. Each well was labeled with details of the treatment and the appropriate exposure time. Separate treatment plates were used for the test item, negative and positive controls to avoid the possibility of cross contamination occurring. Before treatment, the 7 day old tissues were transferred from the ‘arrival plates’ into the wells of the ‘treatment plates’ containing the maintenance medium. Triplicate tissues were treated with 30 mg of the test item for 10 minutes. The tissues were dosed at regular timed intervals to allow for the period taken to rinse each insert following exposure and to ensure each tissue received an equal exposure time. Triplicate tissues were treated with 30 μL of solution A to serve as negative controls and triplicate tissues were treated with 30 μL of 2% w/v SDS to serve as positive controls. The plates were incubated at 37 °C, 5% CO2 in air during the exposure time.
At the end of the relevant exposure period, each tissue insert was removed from the well using forceps and rinsed using a wash bottle containing Dulbecco’s Phosphate Buffered Saline (DPBS) without Ca++ and Mg++. Rinsing was achieved by filling and emptying each tissue insert using a constant soft stream of DPBS to gently remove any residual test item. Excess DPBS was removed by blotting the bottom of the insert with absorbent paper. Each tissue was placed into a pre-labeled 24-well plate designated ‘holding plate’ containing 300 μL of maintenance medium (at room temperature) until all the tissues were rinsed. Following rinsing, the tissues were transferred to a pre-labeled 24-well plate designated ‘MTT Loading plate’ containing 300 μL of a 0.5 mg/mL MTT solution freshly prepared in maintenance medium. The MTT loading plate was placed into an incubator for approximately three hours at 37 °C, 5% CO2 in air.
At the end of the incubation period the inserts were rinsed twice with phosphate buffered saline and blotted on absorbent paper to remove residual MTT solution and transferred to a pre-labeled 24-well plate designated ‘MTT extraction plate’ containing 0.75 mL of isopropanol in each of a sufficient number of wells. An extra 0.75 mL of isopropanol was added onto each tissue and the plate sealed to prevent isopropanol evaporation. The plate was wrapped in aluminum foil (to protect from light) and allowed to stand overnight at room temperature to extract the formazan crystals out of the tissue.
At the end of the extraction period, each tissue insert was pierced with a pipette fitted with a 1000 μL tip and the extraction solution forced vigorously up and down through the tissue insert until a homogeneous solution was obtained. The empty inserts were discarded. For each tissue triplicate 200 μL samples were transferred to the appropriate wells of a pre-labeled 96-well plate. 200 μL of isopropanol alone was added to three wells designated as ‘blanks’. The optical density was measured (quantitative measurement of tissue viability) at 562nm (OD562) using the Anthos 2001 microplate reader.
Results and discussion
In vivo
Results
- Irritation parameter:
- other: Relative mean viability (%)
- Basis:
- mean
- Time point:
- other: 10-minute exposure
- Score:
- 43.2
- Remarks on result:
- other: Irritant
- Irritant / corrosive response data:
- The relative mean viability of the test item treated tissues after a 10-Minute exposure period was 43.2%.
Any other information on results incl. tables
Assessment of Direct Test Item Reduction of MTT
The MTT solution containing the test item turned blue which indicated that the test item directly reduced MTT and therefore the MTT viability assay was performed in parallel on viable and freeze-killed tissues.
Assay Acceptance Criterion
The relative mean tissue viability for the positive control treated tissues was 17.8% relative to the negative control treated tissues.
The quality criterion required for the acceptance of results in the test was satisfied.
Assessment of Eye Irritation Potential – Viability of HCE Tissues
Item |
OD562of |
Mean OD562 |
Mean OD562of tissues corrected for MTT direct reduction (-0.056) |
Relative Mean Viability (%) |
Negative ControlÅ |
0.795 |
0.815 |
na |
100* |
0.815 |
||||
0.834 |
||||
Positive ControlÅ |
0.144 |
0.145 |
na |
17.8 |
0.148 |
||||
0.143 |
||||
Test Item |
0.392 |
0.408 |
0.352 |
43.2 |
0.412 |
||||
0.419 |
Corrected viabilityof treated killed tissues |
= |
0.082 (tkt)-0.026 (ukt) = 0.056 |
Applicant's summary and conclusion
- Interpretation of results:
- irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test item was classified as irritant.
- Executive summary:
The eye irritation potential of the test substance, TM 11-0230 was assessed using the SkinEthic reconstructed Human Corneal Epithelium model. The relative mean viability of the test item treated tissues after a 10-Minute exposure period was 43.2%. The test item was therefore considered to be an irritant.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.